Cargando…

The Role of Metformin in the Management of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Its prevalence ranges 10–24% in the general population, reaching 60–95% and 28–55% in obese and diabetic patients, respectively. Although the etiology of NAFLD is still unclear, several lines of evidences have indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazza, Angela, Fruci, Barbara, Garinis, Giorgia Anna, Giuliano, Stefania, Malaguarnera, Roberta, Belfiore, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238361/ https://www.ncbi.nlm.nih.gov/pubmed/22194737 http://dx.doi.org/10.1155/2012/716404

Ejemplares similares

Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
por: Fruci, Barbara, et al.
Publicado: (2013)

The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
por: Malaguarnera, Roberta, et al.
Publicado: (2014)

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
por: Malaguarnera, Roberta, et al.
Publicado: (2012)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011)

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
por: Malaguarnera, Roberta, et al.
Publicado: (2017)

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
por: Vella, Veronica, et al.
Publicado: (2019)

Metformin: When Should We Fear Lactic Acidosis?
por: Di Mauro, Stefania, et al.
Publicado: (2022)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells
por: De Marco, Paola, et al.
Publicado: (2015)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
por: Belfiore, A., et al.
Publicado: (2009)

Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Role of Angiogenesis in the Pathogenesis of NAFLD
por: Lei, Lin, et al.
Publicado: (2021)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018)

Dual Role of MicroRNAs in NAFLD
por: Ceccarelli, Sara, et al.
Publicado: (2013)

The role of NAFLD in cardiometabolic disease: an update
por: Faasse, Sarah, et al.
Publicado: (2018)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

Role of Ultrasound Methods for the Assessment of NAFLD
por: Petzold, Golo
Publicado: (2022)

The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
por: Vonderlin, Joscha, et al.
Publicado: (2023)

Role of ammonia in NAFLD: An unusual suspect
por: Thomsen, Karen Louise, et al.
Publicado: (2023)

Environmental Pollution: A Tangible Risk for NAFLD Pathogenesis
por: Arciello, Mario, et al.
Publicado: (2013)

Role of NKT Cells in the Pathogenesis of NAFLD
por: Tajiri, Kazuto, et al.
Publicado: (2012)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
por: Cholankeril, Rosann, et al.
Publicado: (2018)

The lauric acid-activated signaling prompts apoptosis in cancer cells
por: Lappano, Rosamaria, et al.
Publicado: (2017)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
por: Patel Chavez, Chandani, et al.
Publicado: (2021)

Insights into the Role of PPARβ/δ in NAFLD
por: Chen, Jiapeng, et al.
Publicado: (2018)

The Emerging Role of B Cells in the Pathogenesis of NAFLD
por: Barrow, Fanta, et al.
Publicado: (2021)

GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond
por: Mahlapuu, Margit, et al.
Publicado: (2022)

Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
por: An, Lingxuan, et al.
Publicado: (2023)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
por: Hanna, David J., et al.
Publicado: (2021)

Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2021)

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway
por: Matà, Roberta, et al.
Publicado: (2015)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7jjdtf3j4ico058droa34v0qlg